NCT02895230View on ClinicalTrials.gov

Androgen-Deprivation Therapy and Cardiovascular Risk: A Nationwide Population-based Cohort Study

CompletedOBSERVATIONAL
Enrollment

38,690

Participants

Timeline

Start Date

January 1, 2016

Primary Completion Date

March 21, 2016

Study Completion Date

May 17, 2022

Conditions
Prostate CancerAndrogen-deprivation Therapy
Interventions
OTHER

Standard care

An extraction from French Health Reimbursement Agency database and French hospital discharge database will be performed using a simplified request based on inclusion criteria but the extraction will encompass a 4-year period to ensure sufficient follow-up.

Trial Locations (1)

35033

CHU de Rennes, Rennes

All Listed Sponsors
lead

Rennes University Hospital

OTHER

NCT02895230 - Androgen-Deprivation Therapy and Cardiovascular Risk: A Nationwide Population-based Cohort Study | Biotech Hunter | Biotech Hunter